Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Kevlar in the classroom: teacher union warns of violence rise in Manitoba

January 11, 2026

Google’s AI Inbox could be a glimpse of Gmail’s future

January 11, 2026

The full history of TiVo, and how it changed TV forever

January 11, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

January 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

January 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global Clinical Trial Management Systems Market Forecasted to Reach $2.74 Billion by 2027
Press Release

Global Clinical Trial Management Systems Market Forecasted to Reach $2.74 Billion by 2027

By News RoomNovember 21, 20234 Mins Read
Global Clinical Trial Management Systems Market Forecasted to Reach .74 Billion by 2027
Share
Facebook Twitter LinkedIn Pinterest Email
Global Clinical Trial Management Systems Market Forecasted to Reach .74 Billion by 2027

Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) — The “Global Clinical Trial Management System Market Report 2023” report has been added to ResearchAndMarkets.com’s offering.

The global clinical trial management systems (CTMS) market is projected to expand from $1.46 billion in 2022 to an impressive $2.74 billion by 2027, charting a compound annual growth rate (CAGR) of 13.3%. This growth trajectory is underpinned by a burgeoning number of clinical trials worldwide and significant strides in technological advancements.

The clinical trial management systems market has demonstrated resilience and growth potential amidst global challenges. The Russia-Ukraine conflict, which has led to economic sanctions, inflated commodity prices, and supply chain disruptions, contributed to a global economic tremor affecting numerous markets. Despite these hurdles, the CTMS market continued its upward trend, primarily fueled by the increasing volume of clinical trials.

Clinical trials, integral in assessing novel medical procedures and treatments, witnessed a significant upsurge. Data from Trialtrove revealed that the number of Phase I-III clinical trials initiated rose from 9,819 in 2020 to 10,410 in 2021, marking a 6% increase. Notably, non-COVID-19 trial initiations surged by 22% in 2021, further catalyzing the demand for efficient CTMS.

Technological advancements are at the forefront of this market growth. Leading companies in the CTMS arena are leveraging new technologies to solidify their market presence. A case in point is eClinical Solutions LLC, which, in February 2021, launched the elluminate Clinical Trial Management System. This platform integrates clinical operations data, offering improved trial performance and operational oversight, thereby enhancing decision-making processes.

Geographically, North America dominated the CTMS market in 2022, while the Asia-Pacific region is poised to emerge as the fastest-growing market in the coming years. The comprehensive market analysis covers various regions, including Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, with detailed insights into countries like Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, the USA, Italy, Spain, and Canada.

The CTMS market is home to major players such as International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, and Parexel International Corporation, among others. A noteworthy development in the market was the acquisition of Bio-Optronics Inc. by Advarra Technology Solutions Inc. in March 2021, a strategic move that expanded Advarra’s range of site connections and healthcare systems.

This report is part of a comprehensive series offering detailed statistics, market size, regional shares, competitive landscape, and segment analysis. It provides a holistic view of the market, covering various aspects such as product types (enterprise-based and site-based), components (software and services), delivery modes (web-based, on-premise, and cloud-based), and end-users (pharmaceutical and biotechnology firms, medical device firms, CROs, and others).

The clinical trial management systems market, encompassing revenues from treatment, prevention, screening, and supportive care trials management services, presents a valuable opportunity for stakeholders in the healthcare and technology sectors. This growth trajectory is a testament to the market’s resilience and adaptability in the face of global economic challenges.

A selection of companies mentioned in this report includes

  • International Business Machines Corporation
  • Oracle Corporation
  • Cognizant Technology Solutions India Private Limited
  • Laboratory Corporation of America Holdings
  • Wipro Limited
  • Veeva Systems Inc
  • Medidata Solutions
  • BioClinica Inc.
  • Calyx
  • Clario
  • Advarra Inc
  • ArisGlobal LLC
  • MasterControl Solutions Inc.
  • Medrio Inc.
  • Anju Software Inc.
  • Forte Research System Inc
  • Cmed Clinical Services
  • OmniComm Systems Inc.
  • MedNet Solutions Inc.
  • DSG Inc.
  • eClinical Solutions LLC
  • Bioclinical Partners (BCP)
  • Flex Databases
  • DataTrak International Inc.
  • OpenClinica LLC
  • SimpleTrials
  • PHARMASEAL International Ltd
  • Dacima Software Inc.
  • RealTime Software Solutions LLC

For more information about this report visit https://www.researchandmarkets.com/r/5gr28v

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Clinical Trial Management System Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

DeFi Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors as V1 Protocol Launch Nears

Mutuum Finance (MUTM) Reports Ongoing Roadmap Progress With Halborn Security Audit Finalized

New Crypto Mutuum Finance (MUTM) Reports Development Progress with Over $19.7M Raised Since 2025

Stella Adler Foundation Reading of ‘All The President’s Men’ Sells Out With Cast Including: Mark Ruffalo, Ethan Hawke, Amy Brenneman, Don Cheadle, Kaley Cuoco, Laurence Fishburne, Spencer Garrett, Rob Morrow, Tom Pelphrey, Susan Traylor, Missy Yager, and More

Stella Adler Foundation Reading of ‘All The President’s Men’ Sells Out With Cast Including: Mark Ruffalo, Ethan Hawke, Amy Brenneman, Don Cheadle, Kaley Cuoco, Laurence Fishburn, Spencer Garrett, Rob Morrow, Tom Pelphrey, Susan Traylor, Missy Yager, and More

Property Value Explained by Real Estate Expert Luke Williams of Bowling Green, KY for HelloNation

Cabinetry Expert Michael Quatela of Rochester, NY Discusses When It’s Time for a Cabinet Upgrade in HelloNation

Editors Picks

Google’s AI Inbox could be a glimpse of Gmail’s future

January 11, 2026

The full history of TiVo, and how it changed TV forever

January 11, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardent Health

January 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

January 11, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

DeFi Crypto Mutuum Finance (MUTM) Reaches Over 18,700 Investors as V1 Protocol Launch Nears

January 11, 2026

Mutuum Finance (MUTM) Reports Ongoing Roadmap Progress With Halborn Security Audit Finalized

January 11, 2026

New Crypto Mutuum Finance (MUTM) Reports Development Progress with Over $19.7M Raised Since 2025

January 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version